{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:36:01Z","timestamp":1788341761622,"version":"build-2803163510"},"reference-count":48,"publisher":"American Association for Cancer Research (AACR)","issue":"2","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The radiomimetic enediyne C-1027 induces almost exclusively DNA double-strand breaks (DSB) and is extremely cytotoxic. Unique among radiomimetics, ataxia-telangiectasia mutated (ATM) is dispensable for cellular responses to C-1027-induced DNA damage. This study explores the biological activity of three recently bioengineered C-1027 analogues: 7\u2033-desmethyl-C-1027 (desmethyl), 20\u2032-deschloro-C-1027 (deschloro), and 22\u2032-deshydroxy-C-1027 (deshydroxy). Each compound maintains the characteristic ability of radiomimetics to cleave DNA in cell-free systems, varying in activity from 2-fold (deschloro) to 55-fold (desmethyl) less than C-1027. The induction of cellular DNA breaks based on pulsed field gel electrophoresis, comet analysis, and \u03b3H2AX activation was in the same rank order as cell-free DNA break induction, although the amount of breaks induced by desmethyl is greatly reduced compared with the other analogues. Despite the disparity in inducing DNA DSBs, all of the analogues produced G2-M cell cycle arrest and activated DNA DSB damage response proteins, such as p53-Ser15 and Chk2-Thr68, at concentrations in concordance with their ability to inhibit cell growth. Interestingly, of the three analogues, only the desmethyl-induced DNA damage response was similar to C-1027, as it did not cause hypersensitive cell growth inhibition in the absence of ATM nor require the kinase to phosphorylate p53 or Chk2. These findings show that simple modifications of the chromophore of C-1027 can result in varied induction of, and cellular response to, DNA DSBs. [Cancer Res 2007;67(2):773\u201381]<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-2893","type":"journal-article","created":{"date-parts":[[2007,1,18]],"date-time":"2007-01-18T16:53:23Z","timestamp":1169139203000},"page":"773-781","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Single Chemical Modifications of the C-1027 Enediyne Core, a Radiomimetic Antitumor Drug, Affect Both Drug Potency and the Role of Ataxia-Telangiectasia Mutated in Cellular Responses to DNA Double-Strand Breaks"],"prefix":"10.1158","volume":"67","author":[{"given":"Daniel R.","family":"Kennedy","sequence":"first","affiliation":[{"name":"1Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta S.","family":"Gawron","sequence":"additional","affiliation":[{"name":"1Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Ju","sequence":"additional","affiliation":[{"name":"2Division of Pharmaceutical Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Liu","sequence":"additional","affiliation":[{"name":"2Division of Pharmaceutical Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Shen","sequence":"additional","affiliation":[{"name":"2Division of Pharmaceutical Sciences,"},{"name":"3University of Wisconsin National Cooperative Drug Discovery Group, and"},{"name":"4Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry A.","family":"Beerman","sequence":"additional","affiliation":[{"name":"1Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,1,18]]},"reference":[{"key":"2022061623361534700_B1","doi-asserted-by":"crossref","unstructured":"Abraham RT. PI 3-kinase related kinases: \u2018big\u2019 players in stress-induced signaling pathways. DNA Repair (Amst)\u20082004; 3: 883\u20137.","DOI":"10.1016\/j.dnarep.2004.04.002"},{"key":"2022061623361534700_B2","doi-asserted-by":"crossref","unstructured":"Shiloh Y. ATM and ATR: networking cellular responses to DNA damage. Curr Opin Genet Dev\u20082001; 11: 71\u20137.","DOI":"10.1016\/S0959-437X(00)00159-3"},{"key":"2022061623361534700_B3","doi-asserted-by":"crossref","unstructured":"Iliakis G, Wang Y, Guan J, Wang H. DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene\u20082003; 22: 5834\u201347.","DOI":"10.1038\/sj.onc.1206682"},{"key":"2022061623361534700_B4","doi-asserted-by":"crossref","unstructured":"Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer\u20082003; 3: 155\u201368.","DOI":"10.1038\/nrc1011"},{"key":"2022061623361534700_B5","doi-asserted-by":"crossref","unstructured":"Li L, Zou L. Sensing, signaling, and responding to DNA damage: organization of the checkpoint pathways in mammalian cells. J Cell Biochem\u20082005; 94: 298\u2013306.","DOI":"10.1002\/jcb.20355"},{"key":"2022061623361534700_B6","doi-asserted-by":"crossref","unstructured":"Fernandez-Capetillo OH-TC, Celeste A, Ward I, et al. DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat Cell Biol\u20082002; 4: 993\u20137.","DOI":"10.1038\/ncb884"},{"key":"2022061623361534700_B7","doi-asserted-by":"crossref","unstructured":"Barlow C, Brown KD, Deng CX, Tagle DA, Wynshaw-Boris A. Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways. Nat Genet\u20081997; 17: 453\u20136.","DOI":"10.1038\/ng1297-453"},{"key":"2022061623361534700_B8","doi-asserted-by":"crossref","unstructured":"Helt CE, Cliby WA, Keng PC, Bambara RA, O'Reilly MA. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage. J Biol Chem\u20082005; 280: 1186\u201392.","DOI":"10.1074\/jbc.M410873200"},{"key":"2022061623361534700_B9","unstructured":"Ziv Y, Jaspers NG, Etkin S, et al. Cellular and molecular characteristics of an immortalized ataxia-telangiectasia (group AB) cell line. Cancer Res\u20081989; 49: 2495\u2013501."},{"key":"2022061623361534700_B10","doi-asserted-by":"crossref","unstructured":"Choudhury A, Cuddihy A, Bristow RG. Radiation and new molecular agents part I: targeting ATM-ATR checkpoints, DNA repair, and the proteasome. Semin Radiat Oncol\u20082006; 16: 51\u20138.","DOI":"10.1016\/j.semradonc.2005.08.007"},{"key":"2022061623361534700_B11","doi-asserted-by":"crossref","unstructured":"Povirk LF. DNA damage and mutagenesis by radiomimetic DNA-cleaving agents: bleomycin, neocarzinostatin, and other enediynes. Mutat Res\u20081996; 355: 71\u201389.","DOI":"10.1016\/0027-5107(96)00023-1"},{"key":"2022061623361534700_B12","doi-asserted-by":"crossref","unstructured":"Smith AL, Nicolaou KC. The enediyne antibiotics. J Med Chem\u20081996; 39: 2103\u201317.","DOI":"10.1021\/jm9600398"},{"key":"2022061623361534700_B13","doi-asserted-by":"crossref","unstructured":"Sutherland BM, Bennett PV, Sidorkina O, Laval J. Clustered damages and total lesions induced in DNA by ionizing radiation: oxidized bases and strand breaks. Biochemistry\u20082000; 39: 8026\u201331.","DOI":"10.1021\/bi9927989"},{"key":"2022061623361534700_B14","doi-asserted-by":"crossref","unstructured":"Xu YJ, Zhen YS, Goldberg IH. C1027 chromophore, a potent new enediyne antitumor antibiotic, induces sequence-specific double-strand DNA cleavage. Biochemistry\u20081994; 33: 5947\u201354.","DOI":"10.1021\/bi00185a036"},{"key":"2022061623361534700_B15","doi-asserted-by":"crossref","unstructured":"Kirk CA, Goodisman J, Beerman TA, Gawron LS, Dabrowiak JC. Kinetics of cleavage of intra- and extracellular simian virus 40 DNA with the enediyne anticancer drug C-1027. Biophys Chem\u20081997; 63: 201\u20139.","DOI":"10.1016\/S0301-4622(96)02217-X"},{"key":"2022061623361534700_B16","doi-asserted-by":"crossref","unstructured":"Nicolaou KC, Smith AL, Yue EW. Chemistry and biology of natural and designed enediynes. Proc Natl Acad Sci U S A\u20081993; 90: 5881\u20138.","DOI":"10.1073\/pnas.90.13.5881"},{"key":"2022061623361534700_B17","doi-asserted-by":"crossref","unstructured":"Elmroth K, Nygren J, Martensson S, Ismail IH, Hammarsten O. Cleavage of cellular DNA by calicheamicin \u03b31. DNA Repair (Amst)\u20082003; 2: 363\u201374.","DOI":"10.1016\/S1568-7864(02)00235-5"},{"key":"2022061623361534700_B18","doi-asserted-by":"crossref","unstructured":"Beerman TA, Goldberg IH. The relationship between DNA strand-scission and DNA synthesis inhibition in HeLa cells treated with neocarzinostatin. Biochim Biophys Acta\u20081977; 475: 281\u201393.","DOI":"10.1016\/0005-2787(77)90019-3"},{"key":"2022061623361534700_B19","doi-asserted-by":"crossref","unstructured":"Beerman TA. Cellular DNA damage by the antitumor protein macromomycin and its relationship to cell growth inhibition. Biochem Biophys Res Commun\u20081978; 83: 908\u201314.","DOI":"10.1016\/0006-291X(78)91481-X"},{"key":"2022061623361534700_B20","doi-asserted-by":"crossref","unstructured":"Turenne GA, Paul P, Laflair L, Price BD. Activation of p53 transcriptional activity requires ATM's kinase domain and multiple N-terminal serine residues of p53. Oncogene\u20082001; 20: 5100\u201310.","DOI":"10.1038\/sj.onc.1204665"},{"key":"2022061623361534700_B21","doi-asserted-by":"crossref","unstructured":"McHugh MM, Gawron LS, Matsui S, Beerman TA. The antitumor enediyne C-1027 alters cell cycle progression and induces chromosomal aberrations and telomere dysfunction. Cancer Res\u20082005; 65: 5344\u201351.","DOI":"10.1158\/0008-5472.CAN-05-0015"},{"key":"2022061623361534700_B22","doi-asserted-by":"crossref","unstructured":"Uziel T, Lerenthal Y, Moyal L, Andegeko Y, Mittelman L, Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J\u20082003; 22: 5612\u201321.","DOI":"10.1093\/emboj\/cdg541"},{"key":"2022061623361534700_B23","doi-asserted-by":"crossref","unstructured":"Ismail IH, Nystrom S, Nygren J, Hammarsten O. Activation of ataxia telangiectasia mutated by DNA strand break-inducing agents correlates closely with the number of DNA double strand breaks. J Biol Chem\u20082005; 280: 4649\u201355.","DOI":"10.1074\/jbc.M411588200"},{"key":"2022061623361534700_B24","doi-asserted-by":"crossref","unstructured":"Dziegielewski J, Beerman TA. Cellular responses to the DNA strand-scission enediyne C-1027 can be independent of ATM, ATR, and DNA-PK kinases. J Biol Chem\u20082002; 277: 20549\u201354.","DOI":"10.1074\/jbc.M109897200"},{"key":"2022061623361534700_B25","doi-asserted-by":"crossref","unstructured":"Kennedy DR, Beerman TA. The radiomimetic enediyne C-1027 induces unusual DNA damage responses to double-strand breaks. Biochemistry\u20082006; 45: 3747\u201354.","DOI":"10.1021\/bi052334c"},{"key":"2022061623361534700_B26","doi-asserted-by":"crossref","unstructured":"Liu W, Christenson SD, Standage S, Shen B. Biosynthesis of the enediyne antitumor antibiotic C-1027. Science\u20082002; 297: 1170\u20133.","DOI":"10.1126\/science.1072110"},{"key":"2022061623361534700_B27","doi-asserted-by":"crossref","unstructured":"Van Lanen SG, Dorrestein PC, Christenson SD, et al. Biosynthesis of the \u03b2-amino acid moiety of the enediyne antitumor antibiotic C-1027 featuring \u03b2-amino acyl-S-carrier protein intermediates. J Am Chem Soc\u20082005; 127: 11594\u20135.","DOI":"10.1021\/ja052871k"},{"key":"2022061623361534700_B28","doi-asserted-by":"crossref","unstructured":"Ziv Y, Bar-Shira A, Pecker I, et al. Recombinant ATM protein complements the cellular A-T phenotype. Oncogene\u20081997; 15: 159\u201367.","DOI":"10.1038\/sj.onc.1201319"},{"key":"2022061623361534700_B29","doi-asserted-by":"crossref","unstructured":"McHugh MM, Yin X, Kuo SR, Liu JS, Melendy T, Beerman TA. The cellular response to DNA damage induced by the enediynes C-1027 and neocarzinostatin includes hyperphosphorylation and increased nuclear retention of replication protein a (RPA) and trans inhibition of DNA replication. Biochemistry\u20082001; 40: 4792\u20139.","DOI":"10.1021\/bi001668t"},{"key":"2022061623361534700_B30","doi-asserted-by":"crossref","unstructured":"Tice RR, Agurell E, Anderson D, et al. Single cell gel\/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen\u20082000; 35: 206\u201321.","DOI":"10.1002\/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J"},{"key":"2022061623361534700_B31","doi-asserted-by":"crossref","unstructured":"Povirk LF, Houlgrave CW. Effect of apurinic\/apyrimidinic endonucleases and polyamines on DNA treated with bleomycin and neocarzinostatin: specific formation and cleavage of closely opposed lesions in complementary strands. Biochemistry\u20081988; 27: 3850\u20137.","DOI":"10.1021\/bi00410a049"},{"key":"2022061623361534700_B32","doi-asserted-by":"crossref","unstructured":"Xu YJ, Xi Z, Zhen YS, Goldberg IH. Mechanism of formation of novel covalent drug.DNA interstrand cross-links and monoadducts by enediyne antitumor antibiotics. Biochemistry\u20081997; 36: 14975\u201384.","DOI":"10.1021\/bi972101o"},{"key":"2022061623361534700_B33","unstructured":"Liu JS, Kuo SR, Beerman TA, Melendy T. Induction of DNA damage responses by adozelesin is S phase-specific and dependent on active replication forks. Mol Cancer Ther\u20082003; 2: 41\u20137."},{"key":"2022061623361534700_B34","doi-asserted-by":"crossref","unstructured":"Fernandez-Capetillo O, Lee A, Nussenzweig M, Nussenzweig A. H2AX: the histone guardian of the genome. DNA Repair (Amst)\u20082004; 3: 959\u201367.","DOI":"10.1016\/j.dnarep.2004.03.024"},{"key":"2022061623361534700_B35","doi-asserted-by":"crossref","unstructured":"Banin S, Moyal L, Shieh S, et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science\u20081998; 281: 1674\u20137.","DOI":"10.1126\/science.281.5383.1674"},{"key":"2022061623361534700_B36","doi-asserted-by":"crossref","unstructured":"Walker S, Landovitz R, Ding WD, Ellestad GA, Kahne D. Cleavage behavior of calicheamicin \u03b31 and calicheamicin T. Proc Natl Acad Sci U S A\u20081992; 89: 4608\u201312.","DOI":"10.1073\/pnas.89.10.4608"},{"key":"2022061623361534700_B37","doi-asserted-by":"crossref","unstructured":"Sugiura Y, Uesawa Y, Takahashi Y, Kuwahara J, Golik J, Doyle TW. Nucleotide-specific cleavage and minor-groove interaction of DNA with esperamicin antitumor antibiotics. Proc Natl Acad Sci U S A\u20081989; 86: 7672\u20136.","DOI":"10.1073\/pnas.86.20.7672"},{"key":"2022061623361534700_B38","doi-asserted-by":"crossref","unstructured":"Gao X, Stassinopoulos A, Rice JS, Goldberg IH. Structural basis for the sequence-specific DNA strand cleavage by the enediyne neocarzinostatin chromophore. Structure of the post-activated chromophore-DNA complex. Biochemistry\u20081995; 34: 40\u20139.","DOI":"10.1021\/bi00001a006"},{"key":"2022061623361534700_B39","doi-asserted-by":"crossref","unstructured":"Dedon PC, Goldberg IH. Free-radical mechanisms involved in the formation of sequence-dependent bistranded DNA lesions by the antitumor antibiotics bleomycin, neocarzinostatin, and calicheamicin. Chem Res Toxicol\u20081992; 5: 311\u201332.","DOI":"10.1021\/tx00027a001"},{"key":"2022061623361534700_B40","doi-asserted-by":"crossref","unstructured":"Meschwitz SM, Schultz RG, Ashley GW, Goldberg IH. Selective abstraction of 2H from C-1\u2032 of the C residue in AGC.ICT by the radical center at C-2 of activated neocarzinostatin chromophore: structure of the drug\/DNA complex responsible for bistranded lesion formation. Biochemistry\u20081992; 31: 9117\u201321.","DOI":"10.1021\/bi00153a001"},{"key":"2022061623361534700_B41","doi-asserted-by":"crossref","unstructured":"Xu Y, Zhen Y, Goldberg IH. Enediyne C1027 induces the formation of novel covalent DNA interstrand cross-links and monoadducts. J Am Chem Soc\u20081997; 119: 1133\u20134.","DOI":"10.1021\/ja963444x"},{"key":"2022061623361534700_B42","doi-asserted-by":"crossref","unstructured":"Battigello JM, Cui M, Roshong S, Carter BJ. Enediyne-mediated cleavage of RNA. Bioorg Med Chem\u20081995; 3: 839\u201349.","DOI":"10.1016\/0968-0896(95)00046-J"},{"key":"2022061623361534700_B43","doi-asserted-by":"crossref","unstructured":"Gomez-Lazaro M, Fernandez-Gomez FJ, Jordan J. p53: twenty five years understanding the mechanism of genome protection. J Physiol Biochem\u20082004; 60: 287\u2013307.","DOI":"10.1007\/BF03167075"},{"key":"2022061623361534700_B44","doi-asserted-by":"crossref","unstructured":"Sedelnikova OA, Rogakou EP, Panyutin IG, Bonner WM. Quantitative detection of (125)IdU-induced DNA double-strand breaks with \u03b3-H2AX antibody. Radiat Res\u20082002; 158: 486\u201392.","DOI":"10.1667\/0033-7587(2002)158[0486:QDOIID]2.0.CO;2"},{"key":"2022061623361534700_B45","doi-asserted-by":"crossref","unstructured":"Li J, Stern DF. Regulation of CHK2 by DNA-dependent protein kinase. J Biol Chem\u20082005; 280: 12041\u201350.","DOI":"10.1074\/jbc.M412445200"},{"key":"2022061623361534700_B46","doi-asserted-by":"crossref","unstructured":"Wang XQ, Redpath JL, Fan ST, Stanbridge EJ. ATR dependent activation of Chk2. J Cell Physiol\u20082006; 208: 613\u20139.","DOI":"10.1002\/jcp.20700"},{"key":"2022061623361534700_B47","doi-asserted-by":"crossref","unstructured":"Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature\u20082003; 421: 499\u2013506.","DOI":"10.1038\/nature01368"},{"key":"2022061623361534700_B48","doi-asserted-by":"crossref","unstructured":"Niedernhofer LJ, Lalai AS, Hoeijmakers JH. Fanconi anemia (cross)linked to DNA repair. Cell\u20082005; 123: 1191\u20138.","DOI":"10.1016\/j.cell.2005.12.009"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/2\/773\/2866757\/773.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/2\/773\/2866757\/773.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T04:21:12Z","timestamp":1655439672000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/2\/773\/533569\/Single-Chemical-Modifications-of-the-C-1027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,15]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2007,1,18]]},"published-print":{"date-parts":[[2007,1,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-2893","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,15]]}}}